Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,240 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
The Ethereum Foundation has quietly moved 5,000 ETH to BitMine in a $10 million over-the-counter trade, marking its s...
With inflation easing and employment softening, the Fed is at a make-or-break moment. Geopolitical risk and energy ma...
Big tech often steals the AI spotlight, but overlooked, nimble players could outperform. This guide breaks down the r...
When Nasdaq and S&P 500 slip together into correction territory, investors face questions and tough choices. This gui...
Bitcoin gains momentum, rising about 6% over the past week and briefly topping $83,000 before pulling back. Traders a...
A prominent real estate fund made a bold $5 million move on InvenTrust Properties as the stock trailed the S&P 500. T...
When the clock ticks past midnight and a leader’s online tirade goes viral, markets and wallets feel the impact. Lear...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
Vanguard’s mid-cap ETF VO is drawing renewed attention as markets tilt toward diversification beyond mega-cap tech. T...
Bitcoin trades in a narrow range as investors digest looming macro data and a cooling appetite for risk. Analysts war...
A DTCC collateral update did not blacklist XRP. The market briefly dumped XRP for other assets, but analysts say the ...